LA JOLLA, CA — Synthetic Genomics Inc. (SGI), a privately held company developing and commercializing genomic driven advancements in a variety of industries, and Lung Biotechnology PBC, a subsidiary of United Therapeutics Corporation (NASDAQ: UTHR), today announced they have expanded their multi-year research and development agreement to develop transplantation-ready pig organs using synthetic genomic advances. […]
Huntingdon (UK): Huntingdon Life Sciences, Harlan Laboratories and three subsidiaries have announced that the combined companies have today re-branded as Envigo (pronounced En-vee-go.). Brian Cass, CEO, commented: “Today we are delighted to officially re-brand as Envigo. This marks a significant milestone for the five companies that came together to create Envigo and demonstrates the great […]
Researchers and scientists rely on antibodies to further research in cancer, neuroscience, immunology, molecular biology and more. But according to a 2015 survey by The Scientist, over 75 percent of researchers are replacing failed antibodies on a routine basis. Given the importance of successful antibodies, and in an effort to help drive accountability within the […]
PLEASANTON, Calif. – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the global launch of the SeqCap EZ MedExome Target Enrichment Kit1, a comprehensive whole exome sequencing (WES) solution designed to increase the discovery and detection of human genetic variants associated with disease while reducing sequencing costs. “The release of the SeqCap EZ MedExome Target […]
Goettingen, Germany — Next to the quickly established state-of-the-art molecular diagnostic products manufactured by AmoyDx, MoBiTec GmbH, Germany, is offering a unique cancer cell detection probe: ProteoGREEN™-gGlu Developed and manufactured by Japan’s Goryo Chemicals, Inc., (https://goryochemical.com), the fluorogenic probe ProteoGREEN™-gGlu constitutes one of the easiest means to detect and image cancer cells by fluorescence microscopy […]
CARLSBAD, Calif. — The bioproduction industry now has access to a new serum replacement for immune cell culture that helps minimize supply and safety risks that have been persistent problems for development of cell therapeutics. The GIBCO CTS Immune Cell SR can be used with many base media in less time, with lower costs and […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced that Sue H. Rataj has been elected to the company’s board of directors, effective immediately. Rataj was chief executive of BP plc’s global petrochemicals business before retiring in April 2011. She was also a group vice president of BP and had held a series […]
CARLSBAD, Calif. — Biopharmaceutical companies developing protein-based therapeutics now have access t o a new t ransient CHO expression syst em designed t o great ly enhance early phase drug screening. The Gibco ExpiCHO Expression System is a fully redesigned transient expression system that enables biologics developers to produce proteins in CHO cells from discovery […]
Melbourne, Australia: Trajan Scientific and Medical (Trajan) continues to expand their technical and research capabilities, announcing a landmark agreement with academia and government in Australia today. Trajan’s latest strategic collaboration with the University of Adelaide, supported by the South Australian Government, sees the realization of a research and development and manufacturing hub based on a […]
CAMBRIDGE, Mass. —– Gen9, Inc., the pioneer in developing scalable technologies for synthesizing and assembling DNA, today announced that it is accepting entries for its fourth annual G-Prize competition. Launched and exclusively run by Gen9, the G-Prize is an annual contest designed to foster groundbreaking research in synthetic biology. The winning entrants are provided access […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
